SAN
DIEGO, Nov. 20, 2023 /PRNewswire/ -- Cardiff
Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology
company leveraging PLK1 inhibition to develop novel therapies
across a range of cancers, today announced that company management
will participate in a fireside chat and 1x1 investor meetings at
the 35th Annual Piper Sandler Healthcare Conference, which is
taking place at the Lotte New York Palace in New York from November
28-30, 2023.
Details of the fireside chat can be found below.
Presenter: Mark Erlander, CEO
Date: 11/29/2023
Time: 10:00 – 10:25 AM ET in Soho
Track
Interested parties can register for and access the live webcast
for Piper Sandler by visiting the
"Events" section of the Cardiff Oncology website. The webcast
replay will be available after the conclusion of the
presentation.
About Cardiff Oncology, Inc.
Cardiff Oncology is a clinical-stage biotechnology company
leveraging PLK1 inhibition, a well-validated oncology drug target,
to develop novel therapies across a range of cancers. The Company's
lead asset is onvansertib, a PLK1 inhibitor being evaluated in
combination with standard-of-care (SoC) therapeutics in clinical
programs targeting indications such as RAS-mutated metastatic
colorectal cancer (mCRC) and metastatic pancreatic ductal
adenocarcinoma (mPDAC), as well as in investigator-initiated trials
in small cell lung cancer (SCLC) and triple negative breast cancer
(TNBC). These programs and the Company's broader development
strategy are designed to target tumor vulnerabilities in order to
overcome treatment resistance and deliver superior clinical benefit
compared to the SoC alone. For more information, please visit
https://www.cardiffoncology.com.
Cardiff Oncology Contact:
James Levine
Chief Financial Officer
858-952-7670
jlevine@cardiffoncology.com
Investor Contact:
Kiki
Patel, PharmD
Gilmartin Group
332-895-3225
Kiki@gilmartinir.com
Media Contact:
Richa
Kumari
Taft Communications
551 344-5592
richa@taftcommunications.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/cardiff-oncology-to-present-at-the-35th-annual-piper-sandler-healthcare-conference-301991867.html
SOURCE Cardiff Oncology, Inc.